TLSI FY 2022 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$12M+47.6% YoY

Gross Profit

$10M81.8% margin

Operating Income

-$36M-293.9% margin

Net Income

-$47M-380.6% margin

EPS (Diluted)

$-1.59

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$368,000

Balance Sheet

Total Assets

$22M

Total Liabilities

$34M

Stockholders' Equity

-$12M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$8M	+47.6%
Gross Profit	$10M	$7M	+40.7%
Operating Income	-$36M	-$24M	-51.6%
Net Income	-$47M	-$29M	-63.6%